Evidence map›Paper›PMID 39688370›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2025

The Trojan Horse of Kidney Transplantation Returns: A Review and Call for Financial Neutrality.

Gabriel M Danovitch

Abstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gabriel M DanovitchDavid Geffen School of Medicine at UCLA and Kidney Transplant Program, Ronald Reagan Medical Center at UCLA, Los Angeles, CA.ORCID 0000-0002-6114-8709

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Publications in both the lay and academic press suggest that the problem of long waiting lists for deceased donor kidney transplants could be solved if only the National Organ Transplant Act were changed to permit various forms of financial incentives to kidney donors. The history of the debate over payments to donors is discussed with particular emphasis on the national and international ramifications of such payments, the effect on normative altruistic donation, and the nature of the relationship between the doctor and the patient in the donor workup process. A way forward is proposed through the promotion of financial neutrality and expanded efforts to prevent CKD.

Indexed as

Kidney TransplantationTissue and Organ ProcurementTissue DonorsAltruismHumansUnited StatesWaiting Lists

Identifiers

PMID39688370
PMCPMC11906008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.